Avid Bioservices Inc (CDMO)

[entdoc]

cj, thanks, as always. do you really think the FDA is going to approve a drug for a given indication when the trial for that indication was stopped "for futility"? I am not saying it is impossible, but I am saying that I would not buy any more stock on that premise. Lightening can strike almost anywhere (but California).
IMO there is an extremely slim chance Bavituimab is going to be used OR approved for treatment of advanced lung cancer. It simply does not make sense to me. I won't belabor the board with my usual diatribe against immunology-oncology applications in advanced cancers of "anything". I do think Bavi (TALCAEPTRX) might eventually have an application as an anti-inflammatory agent, and since cancer is now widely believed to be a response to chronic inflammation (in many/most? cases), then its early use might have cancer-preventative applications. Cheers! ENT doc